The global mHealth apps market size is anticipated to register a considerable CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the growing emphasis on improving the overall health of the patients with the use of smartphones.
Mobile health (mHealth) apps is the sharing and monitoring of health information via smartphone technology, such as health care tracking apps and wearables. This app is used for convenient and secure access of healthcare information on tablet or mobile devices. It has wide range of features and results, which helps in better healthcare management of individual and family. These health mobile apps use mobile technologies and sophisticated data analytics for medical professionals to provide their patients best care possible with accurate diagnosis at low cost from convenient locations.
mHealth app offer various benefits to the patients and healthcare professionals, including request for prescription renewals, management of home medications, secure communication with care team, tracking facility of allergies, immunization, and medical conditions, review of radiology or laboratory reports, optimization of health system, request new appointments, and pre-register for upcoming appointments with medical professionals.
The COVID-19 pandemic outbreak had positive impact on the market. During the pandemic, both non-government and government organization across many regions prompted the use of mobile health apps. This awareness from organization was to manage COVID-19 pandemic effectively with the use of this apps for home monitoring, training, risk assessment, self-management of symptoms, contact tracing, and information sharing, which increases the demand of mHealth apps.
Market Trends, Drivers, Restraints, and Opportunities
- Growing awareness in lifestyle improvement and maintaining physical health along with surging proliferation of smartphones is one of the key factors driving the market growth.
- Increasing recommendations of healthcare professionals to use mobile applications for better patient care is projected to boost the market during the forecast period.
- Rising concerns among users of mHealth apps about data security and privacy issues acts as a major challenge that can restrict the market growth in the coming years.
- Low regulatory approval for mHealth applications is expected to hamper the market growth during the projected timeline.
- Escalating use of social media and increasing application promotions is anticipated to create significant growth opportunities for the market.
Scope of the mHealth Apps Market Report
The report on the global mHealth apps market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
mHealth Apps Market - Global Industry Analysis, Growth, Share, Size, Trends, And Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Types (Fitness Apps [Lifestyle & Stress, Diet & Nutrition, and Exercise & Fitness] and Medical Apps [Disease Management Apps, Diagnostic Apps, Personal Health Record Apps, Remote Monitoring Apps, Medication Management Apps, and Women’s Health Apps])
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Abbott Laboratories; AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc; Pfizer, Inc.; Samsung Electronics Co. Ltd.; Orange S.A.; Allscripts Healthcare Solutions, Inc.; AT&T Inc.; Teladoc Health, Inc.; Johnson and Johnson Pvt., Ltd.; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb Co.; Merck and Co., Inc.; Sanofi S.A.; Qualcomm Technologies, Inc.; Alphabet, Inc.; Apple, Inc.; and Airstrip Technologies, Inc.
|
mHealth Apps Market Segment Insights
Medical apps segment to grow at rapid pace
On the basis of types, the market is bifurcated into fitness apps and medical apps. The fitness apps segment is further divided into lifestyle & stress, diet & nutrition, and exercise & fitness. The medical apps segment is sub-categorized as disease management apps, diagnostic apps, personal health record apps, remote monitoring apps, medication management apps, and women’s health apps. The medical apps segment is expected to grow at a rapid pace during the forecast period owing to the rising awareness for adoption of medical applications among the healthcare professionals and patients for better communication and healthcare outcomes. On the other hand, the fitness apps segment is expected to expand at a substantial growth rate in the coming years attributed to the growing emphasis of individuals on healthy lifestyle and self-health management.
North America to constitute a key market share
In terms of region, the global mHealth apps market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key share of the market during the projected period owing to the growing geriatric population, rising smartphone usage, improving coverage network, increasing prevalence of chronic diseases, and awareness among individuals to adopt mhealth apps in the region. However, the market of Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to the surging internet users, rising proliferation of smartphone, growing population, and rising demand for mHealth apps from healthcare professionals in the region.
Segments
The global mHealth apps market has been segmented on the basis of
Types
- Fitness Apps
- Lifestyle & Stress
- Diet & Nutrition
- Exercise & Fitness
- Medical Apps
- Disease Management Apps
- Diagnostic Apps
- Personal Health Record Apps
- Remote Monitoring Apps
- Medication Management Apps
- Women’s Health Apps
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott Laboratories
- AstraZeneca PLC
- Novartis AG
- GlaxoSmithKline plc
- Pfizer, Inc.
- Samsung Electronics Co. Ltd.
- Orange S.A.
- Allscripts Healthcare Solutions, Inc.
- AT&T Inc.
- Teladoc Health, Inc.
- Johnson and Johnson Pvt., Ltd.
- F. Hoffmann-La Roche Ltd.
- Bristol-Myers Squibb Co.
- Merck and Co., Inc.
- Sanofi S.A.
- Qualcomm Technologies, Inc.
- Alphabet, Inc.
- Apple, Inc.
- Airstrip Technologies, Inc.
Competitive Landscape
Key players competing in the global mHealth apps market are Abbott Laboratories; AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc; Pfizer, Inc.; Samsung Electronics Co. Ltd.; Orange S.A.; Allscripts Healthcare Solutions, Inc.; AT&T Inc.; Teladoc Health, Inc.; Johnson and Johnson Pvt., Ltd.; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb Co.; Merck and Co., Inc.; Sanofi S.A.; Qualcomm Technologies, Inc.; Alphabet, Inc.; Apple, Inc.; and Airstrip Technologies, Inc. Companies are focusing on providing technologically advanced and cloud-based mHealth apps for healthcare and other sectors to maintain their competitive position in the market. Companies have been widely engaged in strategic partnership, merger & acquisition, new product launch, and collaborations to boost their market share and acquiring new buyers.
For instance, in October 2019, Abbott Laboratories, a US based medical devices and healthcare company announced its partnership with Omada Health, a digital care solution, for diabetes care supervision by means of the mhealth coaching apps. In September 2020, Fitbit, a US based fitness and consumer Electronics Company received its approval from CE and US Food and Drug Administration for its ECG application to access heart beat for arterial fibrillation.
Request For Customization
Enquiry Before Buying
Speak With Analyst
